Cancer cells overexpress PD-L1 and/or PD-L2 on their surface, which upon binding to programmed death protein 1 (PD-1) expressed by activated CD8+ T cells, leads to their inhibition and/or apoptosis [11]. The gene discussed is CD8A; the disease is cancer.